Correction to Use of a Lipid-Coated Mesoporous Silica Nanoparticle

This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

Correction to Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice Huan Meng,* Meiying Wang, Huiyu Liu, Xiangsheng Liu, Allen Situ, Bobby Wu, Zhaoxia Ji, Chong Hyun Chang, and Andre E. Nel* ACS Nano 2015, 9 (4), 3540−3557. DOI: 10.1021/acsnano.5b00510

P

age 3555. In the Acknowledgment, the original statement reads “This study was funded by the U.S. Public Health Service Grant RO1 CA133697. H.L. was partially supported by the National Natural Science Foundation of China No. 31271075.” It should be replaced with “This study was funded by the U.S. Public Health Service Grants RO1 CA133697 and U01 CA198846. H.L. was partially supported by the National Natural Science Foundation of China No. 31271075.” The update on the acknowledgment does not affect any of the experimental results, discussions, or conclusions reported in the paper.

Received: May 10, 2016 Published: May 20, 2016 © 2016 American Chemical Society

6416

DOI: 10.1021/acsnano.6b03110 ACS Nano 2016, 10, 6416−6416

Additions and Corrections

www.acsnano.org